|
BMPR1A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.103700E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.461740E-02 |
| Normal-vs-Stage2 |
1.721900E-02 |
| Normal-vs-Stage3 |
8.867800E-02 |
| Normal-vs-Stage4 |
5.787800E-01 |
| Stage1-vs-Stage2 |
6.869400E-01 |
| Stage1-vs-Stage3 |
6.552200E-01 |
| Stage1-vs-Stage4 |
3.237000E-01 |
| Stage2-vs-Stage3 |
4.762400E-01 |
| Stage2-vs-Stage4 |
2.299000E-01 |
| Stage3-vs-Stage4 |
5.097000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.293960E-02 |
| Normal-vs-AfricanAmerican |
3.987700E-02 |
| Normal-vs-Asian |
7.819800E-02 |
| Caucasian-vs-AfricanAmerican |
9.445600E-01 |
| Caucasian-vs-Asian |
5.835000E-01 |
| AfricanAmerican-vs-Asian |
5.211000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.222500E-03 |
| Normal-vs-Female |
6.968200E-01 |
| Male-vs-Female |
2.722400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.571700E-02 |
| Normal-vs-Extreme_Weight |
1.188380E-02 |
| Normal-vs-Obese |
1.651970E-01 |
| Normal-vs-Extreme_Obese |
1.049810E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.924600E-01 |
| Normal_Weight-vs-Obese |
3.580200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.779600E-01 |
| Extreme_Weight-vs-Obese |
1.496570E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.663600E-01 |
| Obese-vs-Extreme_Obese |
1.997200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.882000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.256400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.682320E-03 |
| Normal-vs-Age(81-100Yrs) |
2.935000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.700600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.518400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.042400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.757400E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.142400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.239800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.478100E-02 |
| Normal-VS-Type2 PRCC |
5.70159999999653E-05 |
| Normal-VS-KIRP CIMP |
4.613400E-01 |
| Normal-VS-Unclassified PRCC |
5.535600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.076300E-03 |
| Type1 PRCC-VS-KIRP CIMP |
6.612400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.054800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.091800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.241400E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
8.779400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.237600E-04 |
| Normal-vs-N1 |
8.707800E-01 |
| Normal-vs-N2 |
2.947200E-01 |
| N0-vs-N1 |
5.140500E-03 |
| N0-vs-N2 |
5.936200E-01 |
| N1-vs-N2 |
4.495800E-01 |
|
|
